Aberrant RNA processing in a neurodegenerative disease: The cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis

Neuron

Volumn 20, Issue 3, 1998, Pages 589-602

  Lin, Chien Liang Glenn ^a   Bristol, Lynn A ^a   Jin, Lin ^a   Dykes Hoberg, Margaret ^a   Crawford, Thomas ^a   Clawson, Lora ^a   Rothstein, Jeffrey D ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; GLUTAMIC ACID; PROTEIN EAAT 2; UNCLASSIFIED DRUG;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID; CONTROLLED STUDY; EXON; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; MALE; NERVE CELL DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RNA PROCESSING;

EID: 0032032013     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(00)80997-6     Document Type: Article

References (55)

1. Aoki, M., Lin, C.L.G., Rothstein, J.D., Geller, B.A., Hosler, B.A., Munsat, T.L., Horvitz, H.R., and Brown, R.H. (1998). Mutations in the glutamate transporter EAAT2 gene do not cause abnormal transcripts in ALS. Ann. Neurol. 43, in press.
2. Appel, S.H., Smith, R.G., Engelhardt, J.I., and Stefani, E. (1994). Evidence for autoimmunity in amyotrophic lateral sclerosis. J. Neurol. Sci. 124 (suppl.), 14-19.
3. Arriza, J.L., Fairman, W.A., Wadiche, J.I., Murdoch, G.H., Kavanaugh, M.P., and Amara, S.G. (1994). Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J Neurosci. 14, 5559-5569.
4. Beal, M.F., Ferrante, R.J., Browne, S.E., Matthews, R.T., Kowall, N.W., and Brown, R.H. (1997). Increased 3-nitrotyrosinein both sporadic and familial amyotrophic lateral sclerosis. Ann. Neurol. 42, 644-654.
5. Bensimon, G., Lacomblez, L., and Meininger, V. (1994). A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N. Engl. J. Med. 330, 585-591.
6. Bowling, A.C., Schulz, J.B., Brown, R.H., Jr., and Beal, M.F. (1993). Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem. 61, 2322-2325.
7. Bowling, A.C., Barkowski, E.E., McKenna-Yasek, D., Sapp, P., Horvitz, H.R., Beal, M.F., and Brown, R.H., Jr. (1995). Superoxide dismutase concentration and activity in familial amyotrophic lateral sclerosis. J. Neurochem. 64, 2366-2369.
8. Bristol, L.A., and Rothstein, J.D. (1996). Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex. Ann. Neurol. 39, 676-679.
9. Brooks, B.R. (1994). El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J. Neurol. Sci. 124 (suppl.), 96-107.
10. Brown, R.H., Jr. (1996). Superoxide dismutase and familial amyotrophic lateral sclerosis: new insights into mechanisms and treatments. Ann. Neurol. 39, 145-146.
11. Bruijn, L.I., and Cleveland, D.W. (1996). Mechanisms of selective motor neuron death in ALS: insights from transgenic mouse models of motor neuron disease. Neuropathol. Appl. Neurobiol. 22, 373-387.
12. Campagne, M.V., Lucassen, P.J., Vermeulen, J.P., and Balazs, R. (1995). NMDA and kainate induce internucleosomal DNA cleavage associated with both apoptotic and necrotic cell death in the neonatal rat brain. Eur. J. Neurosci. 7, 1627-1640.
13. 2+ dependent. Neuroreport 6, 945-948.
14. Couratier, P., Hugon, J., Sindou, P., Vallat, J.M., and Dumas, M. (1993). Cell culture evidence for neuronal degeneration in amyotrophic lateral sclerosis being linked to glutamate AMPA/kainate receptors. Lancet 341, 265-268.
15. Couratier, P., Sindou, P., Esclaire, F., Louvel, E., and Hugon, J. (1994). Neuroprotective effects of riluzolein ALS CSF toxicity. Neuropharm. Neurotox. 5, 1012-1014.
16. Didier, M., Bursztajn, S., Adamec, E., Passani, L., Nixon, R.A., Coyle, J.T., Wei, J.Y., and Berman, S.A. (1996). DNA strand breaks induced by sustained glutamate excitoxicity in primary neuronal cultures. J. Neurosci. 17, 2238-2250.
17. Ebihara, K., Masuhiro, Y., Kitamoto, T., Suzawa, M., Uematsu, Y., Yoshizawa, T., Ono, T., Harada, H., Matsuda, K., Hasegawa, T., et al. (1996). Intron retention generates a novel isoform of the murine vitamin D receptor that acts in a dominant negative way on the vitamin D signaling pathway. Mol. Cell. Biol. 16, 3393-3400.
18. Fairman, W.A., Vandenberg, R.J., Arriza, J.L., Kavanaugh, M.P., and Amara, S.G. (1995). An excitatory amino-acid transporterwith properties of a ligand-gated chloride channel. Nature 375, 599-603.
19. Ferrante, R.J., Browne, S.E., Shinobu, L.A., Bowling, A.C., Baik, M.J., MacGarvey, U., Kowall, N.W., Brown, R.H., and Beal, M.F. (1997a). Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J. Neurochem. 69, 2064-2074.
20. Ferrante, R.J., Shinobu, L.A., Schulz, J.B., Matthews, R.T., Thomas, C.E., Kowall, N.W., Gurney, M.E., and Beal, M.F. (1997b). Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation. Ann. Neurol. 42, 326-334.
21. Fischer, U., Liu, Q., and Dreyfuss, G. (1997). The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis. Cell 90, 1023-1029.
22. Furuta, A., Martin, L.J., Lin, C.L.G., Dykes-Hoberg, M., and Rothstein, J.D. (1997). Cellular and synaptic localization of the neuronal glutamate transporters excitatory amino acid transporter 3 and 4. Neuroscience 81, 1031-1042.
23. Gurney, M.E., Cuttings, F.B., Zhai, P., Doble, A., Taylor, C.P., Andrus, P.K., and Hall, E.D. (1996). Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann. Neurol. 39, 147-157.
24. Hagiwara, T., Tanaka, K., Takai, S., Maeno-Hikichi, Y., Mukainaka, Y., and Wada, K. (1996). Genomic organization, promoter analysis, and chromosomal localization of the gene for the mouse glial high-affinity glutamate transporter Slc1a3. Genomics 33, 508-515.
25. Haugeto, O., Ullensvang, K., Levy, L.M., Chaudhry, F.A., Honore, T., Nielsen, M., Lehre, K.P., and Danbolt, N.C. (1996). Brain glutamate transporter proteins form homomultimers. J. Biol. Chem. 271, 27715-27722.
26. Ikonomidou, C., Qin, Y.Q., Labruyere, J., and Olney, J.W. (1996). Motor neuron degeneration induced by excitotoxin agonists has features in common with those seen in the SOD-1 transgenic mouse model of amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 55, 211-224.
27. Ince, P., Stout, N., Shaw, P., Slade, J., Hunziker, W., Heizmann, C.W., and Baimbridge, K.G. (1993). Parvalbumin and calbindin D-28k in the human motor system and in motor neuron disease. Neuropathol. Appl. Neurobiol. 19, 291-299.
28. Kuivenhoven, J.A., Weibusch, H., Pritchard, P.H., Funke, H., Benne, R., Assmann, G., and Kastelein, J.J.P. (1996). An intronic mutation in a lariat branchpoint sequence is a direct cause of an inherited human disorder (fish-eye disease). J. Clin. Invest. 98, 358-364.
29. Kuncl, R.W., Crawford, T.O., Rothstein, J.D., and Drachman, D.B. (1992). Motor neuron diseases. In Diseases of the Nervous System, A.K. Asbury, G.M. McKhann, and W.I. McDonald, eds. (Philadelphia: W.B. Saunders), pp. 1179-1208.
30. Lacomblez, L., Bensimon, G., Leigh, P.M., Guillet, P., and Meininger, V. (1996). Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Lancet 347, 1425-1431.
31. Lee, M.K., Marszalek, J.R., and Cleveland, D.W. (1994). A mutant neurofilament subunit causes massive, selective motor neuron death: implications for the pathogenesis of human motor neuron disease. Neuron 13, 975-988.
32. Lehre, K.P., Levy, L.M., Ottersen, O.P., Storm-Mathisen, J., and Danbolt, N.C. (1995). Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations. J. Neurosci. 15, 1835-1853.
33. Liu, Q., Fischer, U., Wang, F., and Dreyfuss, G. (1997). The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell 90, 1013-1021.
34. Meyer, T., Ludolph, A.C., Morkel, M., Hagemeier, C., and Speer, A. (1997). Genomic organization of the human excitatory amino acid transporter gene GLT-1. Neuroreport 8, 775-777.
35. Miller, R.G., Moore, D., Young, L.A., Armon, C., Barohn, R.J., Bromberg, M.B., Bryan, W.W., Gelinas, D.F., Mendoza, M.C., Neville, H.E., et al. (1996). Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. Neurology 47, 1383-1388.
36. Morrison, M., Harris, K.S., and Roth, M.B. (1997). smg mutants affect the expression of alternatively spliced SR protein mRNAs in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 94, 9782-9785.
37. Rothstein, J.D. (1996). Excitotoxicity hypothesis. Neurology 47, S19-S26.
38. Rothstein, J.D., Tsai, G., Kuncl, R.W., Clawson, L., Cornblath, D.R., Drachman, D.B., Pestronk, A., Stauch, B.L., and Coyle, J.T. (1990). Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann. Neurol. 28, 18-25.
39. Rothstein, J.D., Martin, L.J., and Kuncl, R.W. (1992). Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N. Engl. J. Med. 326, 1464-1468.
40. Rothstein, J.D., Jin, L., Dykes-Hoberg, M., and Kuncl, R.W. (1993). Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc. Natl. Acad. Sci. USA 90, 6591-6595.
41. Rothstein, J.D., Martin, L., Levey, A.I., Dykes-Hoberg, M., Jin, L., Wu, D., Nash, N., and Kuncl, R.W. (1994). Localization of neuronal and glial glutamate transporters. Neuron 13, 713-725.
42. Rothstein, J.D., Van Kammen, M., Levey, A.I., Martin, L.J., and Kuncl, R.W. (1995). Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38, 73-84.
43. Rothstein, J.D., Dykes-Hoberg, M., Pardo, C.A., Bristol, L.A., Jin, L., Kuncl, R.W., Kanai, Y., Hediger, M.A., Wang, Y., Schielke, J., et al. (1996). Antisense knockout of glutamate transporters reveals a predominant role for astroglial glutamate transport in excitotoxicity and clearance of extracellular glutamate. Neuron 16, 675-686.
44. Sakai, N., Santamarina-Fojo, S., Yamashita, S., Matsuzawa, Y., and Brewer, H.B. (1996). Exon 10 skipping caused by intron 10 splice donor site mutation in cholesteryl ester transfer protein gene results in abnormal downstream splice site selection. J. Lipid. Res. 37, 2065-2073.
45. Shaw, P.J. (1994). Excitotoxicity and motor neuron disease: a review of the evidence. J. Neurol. Sci. 124, 6-13.
46. 3H]D-aspartate binding sites in the normal human spinal cord and changes in motor neuron disease: a quantitative autoradiographic study. Brain Res. 655, 195-201.
47. Shaw, P.J., Forrest, V., Ince, P.G., Richardson, J.P., and Wastell, H.J. (1995). CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients. Neurodegeneration 4, 209-216.
48. Siddique, T., and Deng, H.X. (1996). Genetics of amyotrophic lateral sclerosis. Hum. Mol. Genet. 5, 1465-1470.
49. Smith, R.G., Hamilton, S., Hoffman, F., Schneider, T., Nastainczyk, W.C.S., Birnbaumer, L., Stafani, E., and Appel, S.H. (1992). Serum antibodies of L-type calcium channels in patients with amyotrophic lateral sclerosis. N. Engl. J. Med. 327, 1721-1728.
50. + -dependent L-glutamate/L-aspartate transporter GLAST-1 (EAAT-1): gene structure and localization to chromosome 5p11-p12. FEBS Lett. 386, 189-193.
51. Tanaka, K., Watase, K., Manabe, T., Yamada, K., Watanabe, M., Takahashi, K., Iwama, H., Nishikawa, T., Ichihara, N., Hori, S., et al. (1997). Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276, 1699-1702.
52. Trotti, D., Rossi, D., Gjesdal, O., Levy, L.M., Racagni, G., Danbolt, N.C., and Volterra, A. (1996). Peroxynitrite inhibits glutamate transporter subtypes. J. Biol. Chem. 271, 5976-5979.
53. Volterra, A., Trotti, D., and Racagni, G. (1994). Glutamate uptake is inhibited by arachidonic acid and oxygen radicals via two distinct and additive mechanisms. Mol. Pharmacol. 46, 986-992.
54. Wang, Q., Forlino, A., and Marini, J.C. (1996). Alternative splicing in COL1A1 mRNA leads to a partial null allele and two in-frame forms with structural defects in non-lethal osteogenesis imperfecta. J. Biol. Chem. 271, 28617-28623.
55. Wong, P.C., Pardo, C.A., Borchelt, D.R., Lee, M.K., Copeland, N.G., Jenkins, N.A., Sisodia, S.S., Cleveland, D.W., and Price, D.L. (1995). An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14, 1105-1116.